This Cambridge startup is building a ‘foundation model’ for the chest to speed drug trials

Most AI imaging startups build one model per disease. A Cambridge company has raised $20m to build a single model for the whole chest. Then it can spin the rest out of that. Qureight makes AI imaging tools for lung and heart clinical trials. It closed a $20m Series B led by Molten Ventures, the […] This story continues at The Next Web

This story was reported by The Next Web. EUROPES curates Europe's most relevant coverage — read the full report at the original source.

Read full coverage at The Next Web →

This Cambridge startup is building a ‘foundation model’ for the chest to speed drug trials

More from Tech & Startups

Discover what’s next for AI, from the SaaS reckoning to the agent security gap, at TechCrunch Disrupt 2026

Thinking Machines co-founder Lilian Weng left the company citing health reasons, then joined OpenAI

Winamp aims for a comeback with a new music player powered by Deezer

Microsoft’s AI spending became cloud revenue. Meta’s became a cash-flow hole.

Microsoft’s Azure just crossed $100bn a year, and the AI bet mostly paid off

OpenAI is giving 100,000 scientists free AI. Here’s how it can afford to.